China
Africa
Explore chapters and articles related to this topic
The professional sector
Published in Miho Ushiyama, Incorporating Patient Knowledge in Japan and the UK, 2019
Side effects are a concern, but are seen as manageable: In terms of systemic side effects, some studies report that applying strong topical steroids can suppress adrenal function in some cases, but there will be no suppression of adrenal function or growth failure with milder topical steroids. If topical steroids are applied appropriately, there will be few systemic side effects and their safety level is high. In terms of local side effects, atrophy of the skin, capillary dilatation, steroid acne, steroid rosacea, hair growth, stretch marks, and bacterial/fungal/viral skin infections may occur, but discontinuing use and applying other suitable measures will resolve basically everything but stretch marks.(Katō et al., 2016: 129)
Patients preferences for different corticosteroid vehicles are highly variable
Published in Journal of Dermatological Treatment, 2020
Kayla Felix, Emily Unrue, Meyene Inyang, Leah A. Cardwell, Elias Oussedik, Irma Richardson, Steven R. Feldman
Psoriasis is a chronic, immune mediated skin condition requiring consistent treatment adherence for successful management. Approximately 80% of those suffering from psoriasis have mild to moderate or localized disease which is generally treated with topical corticosteroids (1). Those with moderate to severe psoriasis or psoriasis involving hands, feet, face, scalp, or genitals are treated with a combination of topical and systemic medications (1). Side effects of topical corticosteroids include skin atrophy, telangiectasias, striae, acne, steroid rosacea, and hypopigmentation. To prevent these side effects, patients are prescribed the least potent topical for the shortest amount of time required to control disease.
Efficacy of topical latanoprost versus minoxidil and betamethasone valerate on the treatment of alopecia areata
Published in Journal of Dermatological Treatment, 2018
Amal Ahmad El-Ashmawy, Iman Hamed El-Maadawy, Gamal Mohamed El-Maghraby
Local signs and symptoms (irritation, folliculitis, burning sensation, skin atrophy, striae, steroid rosacea, headache and hypertrichosis) were recorded. It was conducted for all patients at each visit every 2 weeks after enrollment in the study, and during follow-up period. All clinical medical events, whether observed by the investigators or reported by the patients and whether or not thought to be drug-related, were considered adverse events.